About iGan Partners
iGan Partners is a venture capital firm founded in 2011. It is primarily based out of Toronto, Canada. As of Feb 2026, iGan Partners is an active investor, having invested in 35 companies, with 2 new investments in the last 12 months. It primarily invests in Seed round in Canada based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Life Sciences. Most recently it participated in the $***** Series D round of Exact Imaging Overall, iGan Partners portfolio has seen 8 acquisitions including key companies like Think Research, Quandl and Akira. A lot of funds co-invest with iGan Partners, with names like MaRS Investment Accelerator Fund sharing a substantial percentage of its portfolio. iGan Partners has team of 37 people including 6 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio Acquisitions
Deals in last 12 months
iGan Partners' List of Top Investments
iGan Partners has a portfolio of 35 companies. Their most notable investments are in Exact Imaging and Exact Imaging.Their portfolio spans across Canada, United States, Israel and 2 more locations. They have invested in Enterprise Applications, HealthTech, Life Sciences and 9 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by iGan Partners:
1. FlipGive
Online platform allow users to raise funds through charitable e-commerce. The app offers cashback rewards for shopping, which can be used to pay for team expenses and balance the budget. It also allows teams to accept fee payments.
Key facts about FlipGive
- Founded Year: 2008
- Location: Toronto (Canada)
- Stage: Series A
- Total Funding till date: $5.86M
- Employee Count: 28 as on Jan 05, 2026
- Investors: FJ Labs, iGan Partners and 6 Others
- Latest Funding Round: Series A, Aug 31, 2023, $*****
- Highlight: Editors' Pick
2. Seg Med
Provider of AI-based clinical data management software and services for researchers. The platform allows the sourcing of data and preparing it in a way that can be used by patients, clinicians, and researchers, as well as for artificial intelligence training. Researchers can curate data, access clinical data, use data analysis tools, and more using the platform and services offered by the company.
Key facts about Seg Med
- Founded Year: 2019
- Location: Stanford (United States)
- Stage: Series A
- Total Funding till date: $17.7M
- Employee Count: 11 as on Dec 31, 2021
- Investors: Blumberg Capital, Novacapital and 17 Others
- Latest Funding Round: Series A, Sep 03, 2024, $*****
- Highlight: Editors' Pick
3. MolecuLight
Provider of point of care device for wound assessment. The company's first product, the i:X, is a hand-held fluorescence imaging device for visualizing bacterial presence and distribution in the skin and chronic wounds. i:X launched in 2015. Founded by Dr. Ralph Da Costa.
Key facts about MolecuLight
- Founded Year: 2013
- Location: Toronto (Canada)
- Stage: Series D
- Total Funding till date: $43.2M
- Employee Count: 49 as on May 27, 2025
- Investors: SWK Holdings, Hayfin and 7 Others
- Latest Funding Round: Series D, Jan 06, 2025, $*****
- Highlight: Editors' Pick
Flosonics Medical is a developer of non-invasive sensors for the management of critically ill patients, performing continuous monitoring of arterial flow with automatic artery detection. The company develops products for fluid responsiveness detection in the ICU, E.D, and operating room. The company's smart-bandage product, FloPatch, is designed to address the clinical needs of critically ill patients and the physicians, nurses, and paramedics who care for them in the ambulance, emergency department, operating room, and intensive care unit. The patch is disposable and is enabled with ultrasound technology.
Key facts about Flosonics Medical
- Founded Year: 2015
- Location: Greater Sudbury (Canada)
- Stage: Series C
- Total Funding till date: $39M
- Employee Count: 30 as on Jul 01, 2024
- Investors: Arboretum Ventures, New Leaf Venture Partners and 14 Others
- Latest Funding Round: Venture Debt, Mar 03, 2025, $*****
- Highlight: Editors' Pick
Exact Imaging has developed a micro-ultrasound based imaging device. The ExactVu system operates at 29MHz waves for higher resolution and is used for imaging prostate cancer and biopsies. The product has an integrated disposable needle biopsy apparatus for visualization and targeting of suspicious small regions. in real-time
Key facts about Exact Imaging
- Founded Year: 2013
- Location: Markham (Canada)
- Stage: Series D
- Total Funding till date: $39.9M
- Employee Count: 26 as on Dec 31, 2024
- Investors: Veddis, iGan Partners and 8 Others
- Latest Funding Round: Series D, Feb 10, 2026, $*****
- Highlight: Editors' Pick
iGan Partners' Year-on-Year Investment Trends
iGan Partners has invested in 35 companies over the last 14 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 3 investments, while as of Feb 2026, it has made 1 investment in this year. Its most recent first time investment was in DOCSI and most recent follow-on round was in Exact Imaging.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 1 | 1 |
2025 | 2 | 1 | 3 |
2024 | 1 | 2 | 3 |
2023 | 0 | 0 | 0 |
2022 | 3 | 2 | 5 |
2021 | 1 | 3 | 4 |
2020 | 0 | 0 | 0 |
2019 | 2 | 2 | 4 |
2018 | 5 | 0 | 5 |
2017 | 1 | 2 | 3 |
iGan Partners' Investments by Stage
iGan Partners has made 16 investments in Seed stage with an average round size of $2.72M and 7 investments in Series A stage with an average round size of $5.87M.Stage of entry | No. of Investments |
|---|---|
Seed | 16 |
Series A | 7 |
Note: We have considered here, only first round of investments
iGan Partners' Investments by Sector
iGan Partners has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Life Sciences, Vertical SaaS and High Tech. Notably, it has invested in 35 Tech companies, 30 Enterprise (B2B) companies, 25 Software companies and at least 10 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 13 |
HealthTech | 12 |
Life Sciences | 9 |
Vertical SaaS | 5 |
High Tech | 4 |
Others | 12 |
Note: We have considered here, only first round of investments
iGan Partners' Investments by Geography
iGan Partners has made most investments in Canada (15), followed by United States where it has made 6 investments.Country | No. of Investments |
|---|---|
Canada | 15 |
United States | 6 |
Israel | 1 |
United Arab Emirates | 1 |
Note: We have considered here, only first round of investments
iGan Partners' recent investments
iGan Partners has made 1 investments in 2026 so far - Exact Imaging.Here are the most recent investments by iGan Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 10, 2026 | Canada | Series D | 1286 | - | |
Aug 09, 2025 | United States | Seed | 9761 | - | |
Jun 05, 2025 | Canada | Seed | 9684 | ||
May 29, 2025 | United States | Seed | 7771 | - | |
Sep 03, 2024 | United States | Series A | 9612 | [+9] |
Acquired companies in iGan Partners' Portfolio
8 companies from iGan Partners' portfolio have been acquired. The most recent acquisition were Think Research in Feb 2024 by Beedie Capital.Here are iGan Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 16, 2024 | - | - | 1554 | |
Jan 04, 2021 | - | - | 4469 | |
Jul 24, 2019 | - | - | 8537 | |
Jul 20, 2019 | - | - | 5399 | |
May 09, 2019 | Jul 09, 2018 | Seed | 4012 |
_1561521265205.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of iGan Partners
iGan Partners has a team of 37 members including 6 Partners and 1 Venture Partner located in Canada, Spain and 1 more location. iGan Partners' team sits on the board of 1 company.Here is a list of top team members in iGan Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Toronto | - | ||
Partner | Toronto | - | ||
Partner | Toronto | - | - | |
Partner | Spain | - | - | |
Partner | Mexico | - | - | |
Partner | Toronto | - | ||
Venture Partner | Toronto |
Co-investors of iGan Partners
Over the past 14 years, 110 investors have co-invested in iGan Partners's portfolio companies. This includes funds and angels.
- Invested before iGan Partners: Techstars, Y Combinator and 17 others have invested in rounds before iGan Partners. There are 2 companies where Techstars has invested before iGan Partners and 1 company where Y Combinator has invested before iGan Partners.
- Top Co-investors of iGan Partners: 38 investors entered a company along with iGan Partners. These include investors like MaRS Investment Accelerator Fund (2 companies).
- Invested after iGan Partners: A total of 53 investors have invested in iGan Partners's portfolio after their investments. Top Investors include BDC (2 companies), MaRS Investment Accelerator Fund (2 companies) and Framework Venture Partners (1 company).
Recent News related to iGan Partners
•
iGan Partners Leads $10 Million Financing of Exact ImagingPR Newswire•Feb 10, 2026•Exact Imaging, iGan Partners
•
iGan invests in surgeon-founded tech firm DOCSI to enhance perioperative supply chainHospital Management•Aug 08, 2025•DOCSI, iGan Partners
•
Cosm Medical Secures Seed+ Funding Round Led by iGan PartnersFinSMEs•Jun 05, 2025•Spring Impact Capital, COSM, iGan Partners
•
•
Segmed: Medical Imaging Data Company Raises $10.4 Million (Series A)Pulse 2.0•Sep 12, 2024•Seg Med, iGan Partners, Advocate Health, Castellan and 8 others
•
•
Advocate Health leads $10.5M in funding for data startupBecker's Hospital Review•Sep 04, 2024•Advocate Health, iGan Partners, Fox Chase Cancer Center
•
Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate HealthPR Newswire•Sep 03, 2024•Seg Med, iGan Partners, Advocate Health, Castellan and 8 others
•
RetiSpec Closes $10 Million in Series A FundingMedical Product Outsourcing•Aug 28, 2024•RetiSpec, iGan Partners
•
RetiSpec Closes $10 Million to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer's DiseaseVision Monday•Jul 29, 2024•RetiSpec, iGan Partners, Lilly, Topconhealthcare and 7 others
